Judiciary Committee

A communication from the Chief, Office of Regulatory Affairs, Bureau of Alcohol, Tobacco, Firearms, and Explosives, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Implementing the Safe Explosives Act" (RIN1140-AA00) received in the Office of the President of the Senate on September 30, 2026; to the Committee on the Judiciary.

A communication from the Chief, Office of Regulatory Affairs, Bureau of Alcohol, Tobacco, Firearms, and Explosives, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Annual Notices on Explosive Materials Storage Facilities to Local Fire Authority" (RIN1140-AA51) received in the Office of the President of the Senate on September 30, 2026; to the Committee on the Judiciary.

A communication from the Chief Regulatory Officer, Citizenship and Immigration Services, Department of Homeland Security, transmitting, pursuant to law, the report of a rule entitled "U.S. Citizenship and Immigration Services Employment-Based Immigrant Visa, Fifth Preference (EB-5) Fee Rule" (RIN1615-AC93) received in the Office of the President of the Senate on September 30, 2026; to the Committee on the Judiciary.

A communication from the Research Director of the Administrative Conference of the United States, transmitting, a report of the recommendations adopted by the Administrative Conference of the United States at its 85th Plenary Session; to the Committee on the Judiciary.

A joint resolution adopted by the Northern Marianas Commonwealth Legislature affirming the Commonwealth of the Northern Mariana Islands' commitment to eliminate the commercial facilitation of birth tourism as evidenced by the enactment of the Business Integrity and Regulation of Tourism Harms Act ("BIRTH Act"); to present updated data demonstrating the effectiveness of existing federal and local measures; and to request continued federal coordination consistent with those efforts; to the Committee on the Judiciary.

A resolution adopted by the Senate of the Northern Marianas Commonwealth Legislature petitioning the United States Congress and the President of the United States to restore and expand federal compensation and health programs for individuals exposed to radiation resulting from United States nuclear weapons testing in the Pacific, including the people of the Commonwealth of the Northern Mariana Islands; to the Committee on the Judiciary.

A concurrent resolution adopted by the Legislature of the State of Louisiana urging the United States Congress to take such actions as are necessary to modify the H-2B temporary nonagricultural program to assist with the labor workforce shortage in the state of Louisiana; to the Committee on the Judiciary.

A communication from the President of the United States, transmitting, pursuant to law, the report of 11 rescissions of budget authority; referred jointly, pursuant to the order of January 30, 1975, as amended by the order of April 11, 1986; to the Committees on Appropriations; the Budget; Health, Education, Labor, and Pensions; Homeland Security and Governmental Affairs; the Judiciary; Foreign Relations; Commerce, Science, and Transportation; and Banking, Housing, and Urban Affairs.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Revision of Applications for Manufacturing and Procurement Quotas" ((21 CFR Part 1303 and 1315)(Docket No. DEA-1278)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1644)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Designation of P2P Methyl Glycidic Acid as a List I Chemical" ((21 CFR Part 1310)(Docket No. DEA-1395)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1356)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1337)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Designation of Phenethyl Halides as List I Chemicals" ((21 CFR Part 1310)(Docket No. DEA-1282)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Assistant General Counsel/Rules Administrator, Federal Bureau of Prisons, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "First Step Act Time Credits-Revisions" (RIN1120-AB83) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical" ((21 CFR Part 1308)(Docket No. DEA-1427)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1442)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substance: Temporary Placement of 7-Hydroxy mitragynine Above a Specified Threshold in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1570)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Placement of Tianeptine in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1596)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1604)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance" ((21 CFR Part 1308)(Docket No. DEA-1632)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1641)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1644)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I" ((21 CFR Part 1308)(Docket No. DEA-1644)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.

A communication from the Acting Section Chief, Drug Enforcement Administration, Department of Justice, transmitting, pursuant to law, the report of a rule entitled "Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V" ((21 CFR Part 1308)(Docket No. DEA-1645)) received in the Office of the President of the Senate on September 23, 2026; to the Committee on the Judiciary.